Core Viewpoint - Puma experienced a significant decline in annual sales and EBIT, indicating a challenging year and the need for strategic changes to return to growth [1][6]. Sales Performance - Annual sales fell 8.1 percent in currency-adjusted terms to 7.29 billion euros, down from 8.39 billion euros in 2024, slightly better than market consensus [1]. - Fourth-quarter sales dropped 20.1 percent, currency adjusted, to 1.56 billion euros, marking a particularly disheartening end to the year [2]. - Sales in all product categories fell by high-single digits: footwear sales decreased by 7.1 percent, apparel by 9.7 percent, and accessories by 8.5 percent, in currency-adjusted terms [5]. Strategic Changes - CEO Arthur Hoeld described 2025 as a reset year, aiming for above-industry growth and healthy profits in the medium term [2]. - The company initiated "strategic reset initiatives" from the third quarter, which contributed to the decline in sales [2]. - Actions taken include stock buybacks, reduced promotional activity, simplification of the product portfolio, and cutting around 1,400 corporate roles [3]. Regional Performance - The Americas saw the largest sales decline, with a 10 percent drop, while Europe, the Middle East, and Africa experienced a decrease of 6.9 percent, and the Asia Pacific region fell by 7.4 percent [4][3]. Financial Indicators - EBIT plummeted in the fourth quarter, falling to minus 357.2 million euros, down from nearly 550 million euros in 2024, although this was slightly better than analysts' expectations [6]. - Puma executives indicated that the company is unlikely to return to growth until 2027, with 2026 expected to be a year of transition [7].

This story was updated at 10:45 am EST BERLIN – Having ended a challenging year with what was Puma‘s worst net loss ever in absolute terms, executives at the German sportswear brand were keen to emphasize plans for a reset and talk about the transitional nature of the coming year. More from WWD In 2025, the brand’s annual sales fell 8.1 percent in currency adjusted terms to 7.29 billion euros, down from 8.39 billion euros in 2024, but slightly better than market consensus. Puma ended last year with a pa ...

Core Insights - Galapagos is undergoing a strategic reset, focusing on business development in inflammation & immunology and oncology, while winding down its cell therapy activities [4][7][17] Financial Performance - The company reported an operating profit of €295.1 million for 2025, primarily due to the recognition of €1.069 billion in deferred income from Gilead [5][8] - Galapagos ended 2025 with approximately €2.998 billion in cash, down from €3.317 billion at the end of 2024, with a significant portion held in U.S. dollars [11][12] Research and Development - The TYK2 inhibitor GLPG3667 achieved positive Phase 2 results in dermatomyositis and systemic lupus erythematosus, but the company lacks the infrastructure for Phase 3 trials and is seeking partners for further development [6][7] Strategic Direction - The company is prioritizing "clinically de-risked opportunities" and leveraging its collaboration with Gilead as a strategic advantage [2][4] - A new leadership team has been assembled, and the board has been refreshed with directors experienced in capital allocation and operations [3][4] Future Guidance - For 2026, the company expects to be cash flow neutral to positive by year-end, with a projected cash outflow of up to €50 million in Q1 related to the wind-down of cell therapy [13][15] - The wind-down of cell therapy activities is expected to be substantially completed by the end of Q3 2026 [13][16]

Centrica plc posted lower earnings in 2025 but raised its dividend and pressed ahead with major investments as it targets a step-up in EBITDA by 2030. The UK-based energy and services group reported adjusted EBITDA of £1.4 billion for 2025, down from £2.3 billion in 2024, with adjusted operating profit falling to £814 million from £1.6 billion. Adjusted earnings per share declined to 11.2p from 19.0p a year earlier, reflecting weaker commodity pricing, nuclear outages, and subdued trading conditions. S ...

Group 1 - The conference call is hosted by Veradigm, featuring remarks from CEO Don Trigg and Interim Chief Officer Lee Westerfield [2][4] - The presentation includes forward-looking statements that are based on current expectations and involve risks and uncertainties [3] - The company does not commit to revising forward-looking statements based on new information or future events [3]

Financial Data and Key Metrics Changes - Revenues rose by 10% year-over-year at the preliminary estimate midpoint, driven by an 11% increase in consolidated shipments [12] - AOI was negative in the range of EUR 1.2 billion to EUR 1.5 billion, with industrial free cash flow also negative, ranging from EUR 1.4 billion to EUR 1.6 billion [12] - The company announced EUR 22 billion worth of charges excluded from AOI, primarily related to product plans and resizing the EV supply chain [11] Business Line Data and Key Metrics Changes - Global shipments increased by 11% in H2 2025 compared to H2 2024, with North American shipments up by 39% [8] - The company launched 10 all-new products in 2025, including the Jeep Cherokee Hybrid and Dodge Charger i6 SIXPACK, which received positive market reception [7][10] - The order book in North America increased by over 150%, driven by demand for new Ram, Jeep, and Dodge products [9] Market Data and Key Metrics Changes - In Europe, the company retained segment leadership in the all-hybrids market and the profitable light commercial vehicle market [8] - Order intake in Europe increased by 13% in H1 2025 compared to H1 2024, with a 23% increase in Q4 2025 alone [9] - The company is experiencing growth in South America and the Middle East and Africa [8] Company Strategy and Development Direction - The company is undergoing a decisive reset to empower regional teams, improve stakeholder relationships, and enhance product plans to align with customer demand [4][5] - A significant investment of $13 billion is planned over the next four years in the U.S. to support new product launches [33] - The company aims to improve manufacturing execution and quality governance, with a focus on customer preferences driving the business strategy [17][18] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about early signs of recovery in H2 2025, with expectations for positive foundational growth in 2026 [5] - The company anticipates a return to positive industrial free cash flow by 2027, with net revenues expected to rise by a mid-single-digit percentage in 2026 [14][15] - Management acknowledged challenges in Europe due to competitive pressures but remains focused on improving operational performance [75] Other Important Information - The company has a strong balance sheet with approximately EUR 46 billion in industrial available liquidity, representing a ratio of 30% to net revenues [15] - The decision to not pay a dividend this year reflects the net loss, and the board has authorized the issuance of up to EUR 5 billion in hybrid bonds to maintain liquidity [15] Q&A Session Summary Question: Clarification on AOI and margin expectations - Management confirmed that they are not contemplating any equity raise and expects continuous improvement in AOI throughout 2026, driven by volume increases and operational efficiencies [24][26] Question: Need for drastic actions in Europe - Management emphasized a growth strategy in North America and Europe, with ongoing investments and product launches, while also focusing on industrial efficiency [32] Question: Hybrid bond rationale - The hybrid bond is intended to strengthen the balance sheet and protect the investment grade, with competitive costs expected [38] Question: Warranty provisions and cash outflows - Management does not expect warranty spend to increase in 2026 compared to 2025, with improvements in product quality anticipated [100] Question: Market share expectations in the U.S. - Management expressed confidence in growing market share in the U.S. due to new product launches and improving retail performance [58]

Core Insights - Zentek Ltd. has announced a strategic reset aimed at capital discipline, sharper execution, and focusing on a smaller number of core platforms with clear paths to value creation [1][4] Strategic Focus - The company will narrow its focus to three core platforms: Albany Graphite, ZenGUARD, and Triera, each with defined milestones and a 24-month roadmap [2] - Non-core initiatives are being paused or wound down to preserve capital and management focus [2] Cost Management - Actions are underway to reduce the company's cost base, including workforce and facility optimization, tighter controls on corporate spending, and a disciplined approach to capital allocation [3] - Future capital raises will be linked to specific milestones rather than open-ended development programs [3] Leadership Changes - The Chief Science Officer, Colin van der Kuur, has departed, and responsibilities have been redistributed among the existing technical leadership team [3] Commitment to Shareholder Value - The CEO emphasized that the reset is about protecting and rebuilding shareholder value, with confidence in the technical expertise and operating team to execute priorities [4] - The company will align its research and development efforts to support the three core platforms and implement new standards for transparency and reporting [4]

How Leaders Can Use December To Reset And Enter 2026 With MomentumAs 2026 approaches, the leaders who pull ahead are the ones who treat this month as a strategic reset rather than an outward pause, starting with these four shifts. https://t.co/kBLa0N5p3F ...

How Leaders Can Use December To Reset And Enter 2026 With MomentumAs 2026 approaches, the leaders who pull ahead are the ones who treat this month as a strategic reset rather than an outward pause, starting with these four shifts. https://t.co/kBLa0N5p3F ...

Core Viewpoint - Fiserv's shares experienced a significant decline of 44% on October 29 and an additional 6.7% on October 30 following a reduction in the company's full-year earnings outlook and the announcement of strategic changes [1][2] Financial Impact - The drop in share price resulted in a loss of $30 billion in Fiserv's market capitalization [2] - Fiserv's organic growth fell to 1% in the third quarter, with margins also declining; sales in the Financial Solutions segment decreased by 3% [4] Earnings Outlook - The company's overall organic revenue growth forecast was revised down to 3.5% to 4.5%, a significant reduction from the previous estimate of around 10% [4] - Within the Financial Solutions unit, digital payments revenues decreased by 5%, and banking-related revenues fell by 7% [4] Strategic Changes - In response to customer complaints regarding fees for the Clover point-of-sale system, Fiserv announced it would reverse recent pricing changes and implement a new technology strategy [3][4] - Management changes were also announced, with Takis Georgakopoulos and Dhivya Suryadevara appointed as co-presidents effective December 1, and Paul Todd named as the incoming chief financial officer [5] Leadership Commentary - CEO Mike Lyons expressed that the recent developments were unexpected and highlighted the challenges faced by the company, indicating that the actions taken are part of a necessary reset and revitalization effort [3][6]